Diskussion zu Datametrex -- Covid19 Test Kits (Seite 3)
eröffnet am 17.12.17 09:05:30 von
neuester Beitrag 09.04.24 00:46:00 von
neuester Beitrag 09.04.24 00:46:00 von
Beiträge: 4.207
ID: 1.269.539
ID: 1.269.539
Aufrufe heute: 11
Gesamt: 291.007
Gesamt: 291.007
Aktive User: 0
ISIN: CA23809L1085 · WKN: A2DYN5 · Symbol: D4G
0,0100
EUR
-18,03 %
-0,0022 EUR
Letzter Kurs 09:12:37 Tradegate
Neuigkeiten
19.09.23 · Accesswire |
21.07.23 · Accesswire |
Werte aus der Branche Hardware
Wertpapier | Kurs | Perf. % |
---|---|---|
1,8700 | +32,62 | |
0,7850 | +7,24 | |
12,040 | +6,55 | |
37,50 | +5,63 | |
6,0000 | +5,26 |
Wertpapier | Kurs | Perf. % |
---|---|---|
813,50 | -2,26 | |
66,51 | -2,46 | |
87,79 | -2,93 | |
20,700 | -3,45 | |
5,6000 | -12,50 |
Beitrag zu dieser Diskussion schreiben
Antwort auf Beitrag Nr.: 75.392.996 von Trashi am 04.03.24 21:55:09
Stefan bereitet seine Wiederkehr vor🤷♂️
Zitat von Trashi: Was geht denn heute hier ab?
Stefan bereitet seine Wiederkehr vor🤷♂️
Was geht denn heute hier ab?
Da haben wir den 1 Cent. Von der pusher Fraktion NIE für möglich gehalten.was folgt jetzt? Ich weiss schon...nachkaufen weil es ja so billig ist. Nun...damit bleibt DM genauso ein kanadischer pennystock wie viele andere ohne Nachhaltigkeit. Eigentlich hatten sie nur Glück das corona kam und dadurch kurzzeitig sehr gut verdienen konnten.
Antwort auf Beitrag Nr.: 75.204.287 von Mafieder am 01.02.24 20:58:33Zitat von StefanMellinger
12.09.23 08:17:33
"Ich freue mich jedenfalls auf die kommende Zeit."
🤦♂️🤦♂️🤦♂️
DataMetrex AI | damals: 0,050 € - und heute: ....
Der hat bestimmt keine Aktien mehr hier, sonst wäre er nicht verstummt
Der hat's richtig gemacht🤷♂️
12.09.23 08:17:33
"Ich freue mich jedenfalls auf die kommende Zeit."
🤦♂️🤦♂️🤦♂️
DataMetrex AI | damals: 0,050 € - und heute: ....
Der hat bestimmt keine Aktien mehr hier, sonst wäre er nicht verstummt
Der hat's richtig gemacht🤷♂️
stefan mellinger
wo ist dieser Schwätzer eigentlich hin? Er war doch hier Dauerpusher DATAMETREX GENERATES OVER $1 MILLION REVENUE IN DECEMBER FOR IT SERVICES
https://www.datametrex.com/post/datametrex-generates-over-1-…"...has recorded over $1 million CAD in revenue with expense of approximately $650K CAD at a gross profit margin of approximately 36% for IT services in December, through its wholly-owned subsidiary, Datametrex Korea."
DATAMETREX SECURES APPROXIMATELY $730K PURCHASE ORDER FROM LOTTE
"Toronto, Canada, January 4, 2024 – Datametrex AI Limited (the ‘Company’ or ‘Datametrex’) (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) is pleased to announce that the Company has received a significant Purchase Order (‘P.O.’) valued at approximately $730,000 from the global conglomerate, LOTTE. This P.O., secured through the Company’s subsidiary, Datametrex Korea on December 29, 2023, represents a substantial step in the Company's ongoing expansion and its successful 'land and expand' strategy with the conglomerate...."https://www.datametrex.com/post/datametrex-secures-approxima…
Eigentlich
So, wenn die firma in 2020 pleite war kam Marshall und hat die Firma nach oben gebracht. Ich habe vertrauen, 431,000 aktien und Interesse das etwas wird, aber klar kann auch alles ins Eis knallen.
Antwort auf Beitrag Nr.: 75.051.129 von Alqvimista am 04.01.24 17:39:04Unterschiedliche Meinungen sind gesund für eine gute Diskussion.
Aber finden Sie es nicht seltsam, dass es jetzt wieder einen neuen Namen gibt.
Normalerweise lautet die Erklärung:
'Mit dem neuen Namen können wir besser mit unserem Kerngeschäft identifiziert werden'.
Aber finden Sie es nicht seltsam, dass es jetzt wieder einen neuen Namen gibt.
Normalerweise lautet die Erklärung:
'Mit dem neuen Namen können wir besser mit unserem Kerngeschäft identifiziert werden'.
Am 15 December habe ich das bekommen
NEWS RELEASEDATAMETREX ANNOUNCES AGM RESULTS, NCIB UPDATES, AND OPTION CANCELLATION
Toronto, Canada, December 15, 2023 – Datametrex AI Limited (the "Company" or "Datametrex'') (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) is pleased to announce the voting results from the Annual and Special Meeting of Shareholders (the “Meeting”) held on December 14, 2023.
At the Meeting, a total of 47,237,387 shares or 11.7% of the issued and outstanding shares of the Company were represented in person and by proxy. Details of all resolutions that were voted upon are set out in the Management Information Circular (the “Circular”) dated October 26, 2023. The Circular is available on SEDAR+ (www.sedarplus.ca).
All the resolutions submitted to shareholders were approved, including: electing three directors of the Company: Charles Park, the Honourable James Peterson and Paul Haber; approving the Company’s new omnibus incentive plan; and approving a name change for the Company.
Normal Course Issuer Bid
The Company is also pleased to announce results of the Company’s successful normal course issuer bid (“NCIB”) which commenced June 8, 2022, and which was subsequently amended to increase the maximum number of shares for repurchase to 34,789,603 shares. The NCIB terminated June 7, 2023 with the repurchase and cancellation by the Company of an aggregate of 34,198,000 shares at an average cost of $0.10 per share for a total of $3,538,930 invested. The Company paid PI Financial Corp. a total of $35,142.86 in fees to conduct the NCIB on behalf of the Company. A copy of the Company’s notice with respect to the NCIB filed with TSXV may be obtained by any shareholder without charge by contacting Charles Park, CEO, at cpark@datametrex.com.
Cancellation of Options
The Company also announces the cancellation of its plan to grant stock options (see press release dated November 13, 2023) pursuant to the Company’s previous stock option plan.
While the grant was approved and announced on November 13, 2023, the Company has decided to cancel its plan to issue incentive stock options for the purchase of up to 24.5 million common shares. This decision is part of the Company's ongoing review and refinement of its compensation strategy.
About Datametrex
Datametrex is an innovative leader in artificial intelligence, machine learning, and healthcare. The Company excels in delivering tools and solutions that enhance operational efficiencies and business outcomes. With a commitment to innovation, Datametrex is dedicated to supporting enterprises by setting a new standard for business protocols through cutting-edge technology. For more on Datametrex’s insights into AI, cybersecurity, telehealth, and healthcare, please visit the company website.
Investor Relations & Communications
Charles Park, CFA
Chief Executive Officer & Director
(416) 901-5611 x203
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
All statements included in this press release that address activities, events, or developments that the Company expects, believes, or anticipates will or may occur in the future are forward-looking statements. These forward-looking statements involve numerous assumptions made by the Company based on its experience, perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. In addition, these statements involve substantial known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections, and other forward-looking statements will prove inaccurate, certain of which are beyond the Company’s control. Except as required by law, the Company does not undertake to revise or update these forward-looking statements after the date hereof or revise them to reflect the occurrence of future unanticipated events.
So ich habe eigentlich eine andere Meinung
Diskussion zu Datametrex -- Covid19 Test Kits